From: Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma
No. of positive assays
No. of patients
No. of PDs (%)
median DFS (months)
median OS (months)
0
18
3 (17)
81
83
1
46
8 (17)
2
45
12 (27)
82
3
27
17 (63)
78
79
4–5
13
9 (69)
66
70